MarketLens
Sign Up

Is Eli Lilly's Aggressive Genetic Medicine Push a Game Changer

4 months ago
SHARE THIS ON:

Is Eli Lilly's Aggressive Genetic Medicine Push a Game Changer

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•4 weeks ago

Prediction: Eli Lilly's Next Growth Wave Could Surprise Investors

Eli Lilly is growing faster than any other mega-cap drugmaker, but a pipeline drug still awaiting approval and falling U.S. prices are pulling the stock in opposite directions.
Stock News•1 months ago

Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.

Novartis reported negative news for its Lp(a)-lowering drug pelacarsen, a setback in a multibillion-dollar cardiovascular race. Eli Lilly, also developing an Lp(a) therapy, may see a competitive openi...
Stock News•3 months ago

Eli Lilly Just Made a $2.8 Billion Bet That Goes Beyond GLP-1 Drugs

Eli Lilly acquired a neuroscience asset for $2.8B, expanding beyond its core GLP-1 franchise as competition in that market intensifies.

Breaking News

View All →

Top Headlines

View More →
Stock News•20 minutes ago

GOOGL, GOOG Investors Have Opportunity to Lead Alphabet Inc. Securities Fraud Lawsuit

Stock News•1 hour ago

CrowdStrike Holdings (CRWD) Laps the Stock Market: Here's Why

Stock News•1 hour ago

Nvidia (NVDA) Surpasses Market Returns: Some Facts Worth Knowing

Stock News•1 hour ago

Apple (AAPL) Stock Falls Amid Market Uptick: What Investors Need to Know

Stock News•1 hour ago

Palo Alto Networks (PANW) Laps the Stock Market: Here's Why